A most important news form yesterday's conference was the

New Post Public Reply Private Reply Replies (2) Message Board
TechGuru
1,177
A most important news form yesterday's conference was the update in Oncology.

This was a bit disorganized but very rich in contents. Two testimonials:

1) Patient with stage 4 Colon Cancer May 2020, treated and in December PET shows no sign of cancer anywhere.

2) January 4th letter from Physician in behalf of Bladder Cancer patient who is not candidate for Chemo. Applies for RTT. Given 6 months to live, now 9 months with no metastatic lesions or spread beyond its borders or CT scan lesions. LL apparently curtailed the spread. Still early but there is hope for survival and possible cure (physician’s words).

These are very powerful statements and, in normal circumstances, should send any small company’s SP to-da-moon. But we are not small and we are getting used to these announcements (still should be earth-shattering)… But seriously, how much is a company that can stop colon cancer worth ??? Or delay it ??? ANY cancer ??? I have an idea but don't want to be accused of drinking my Whiskies too many too early or smoking something while still too green.

OK, OK, back to earth.

So NP is “very excited” (his words). We have 9 patients in Basket trial. 16 originally, 3-4 passed away and 2-3 were “kicked out” or could not come in due to COVID concerns. These are 6 months or more in treatment and several had been diagnosed long time back (very important).

NP's opinion is that 5 patients with more than 6 months’ survival is good enough for BTD filing. We have 9, therefore will request meeting with FDA to discus BTD soon (this month).

I am not excited for the above (exclusively), I am because after all these months there have been deep radio-silence regarding Basket trial results.

We dosed our first patient 9/27/2019 (mTNBC) and NP’s MIL 11/25/2019. First patient in Basket protocol (mBC) 4/15/2020 (if my memory is correct). NP has confirmed that the CTC’s are mostly zero and with reduced CAML’s. They are waiting for CT and MRI results.

Holy macaroni !!!

The importance here is THE TIME LAPSED SINCE !!!, we are referring here to patients from few months back. This is imo extraordinary news. Apoligies for trying to tell you something long term-investors already know, but the truth is, I was beginning to get a bit anxious about Oncology and discounting it as a "no show".

If this works out I really don’t care about COVID or/and HIV.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exciting Developments in Lumwana's Super Pit Expansion

Updated Category News Views 162

Back when Barrick Gold Corporation dropped the news about the Lumwana Super Pit Expansion, traders had their ears perked up. This $2 billion project was set to redefine copper mining in Zambia, and let me tell ya, folks were buzzing like bees at a honey convention. Lumwana Expansion: The Big Picture The official launch ceremony back then saw Zambian President Hakainde...

Continue Reading
Understanding the P/E Ratio for Arbor Realty Trust's Future

Updated Category News Views 97

Understanding Arbor Realty Trust Inc. and Its P/E Ratio Presently, Arbor Realty Trust Inc. (NYSE: ABR) is trading at a price of $7.78, reflecting a decrease of 0.38% for the day. This decline has culminated in a more significant decrease of 12.78% over the past month, and a notable drop of 44.17% over the past year. Such trends pique the interest of long-term shareholders...

Continue Reading
Investors Should Reach Out to Kuehn Law Regarding DRVN Issues

Updated Category News Views 177

Contact Kuehn Law for Driven Brands Holdings Inc. Investors Kuehn Law, PLLC, a law firm specializing in shareholder litigation, is looking into potential fiduciary breaches by officers and directors of Driven Brands Holdings Inc. (NASDAQ: DRVN). The investigation focuses on allegations that insiders misrepresented the company’s integration capabilities of acquired...

Continue Reading
Understanding Revvity's Short Interest and Market Sentiment

Updated Category News Views 118

Revvity short interest: what’s changed Revvity (RVTY) has seen a fresh uptick in short positioning. Since the last report, its short percent of float has climbed by 10.95%. In total, an estimated 4.15 million shares are sold short, which equals 4.46% of the company’s available float. Based on recent trading activity, it would take about 3.81 days, on average, for...

Continue Reading
Upcoming Q3 Results Preview for National Healthcare Properties

Updated Category News Views 189

National Healthcare Properties and Their Upcoming Financial Disclosure National Healthcare Properties, Inc. is set to unveil its financial results for the third quarter, specifically for the period that concluded on September 30. This highly anticipated announcement is scheduled for a Wednesday, following the market close. Webcast Details for the Financial Results To...

Continue Reading